GLP-1 Up
US$ 28.60
glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Updated evidence on cardiovascular and renal effects of agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives | Cardiovascular Diabetology Effects of Semaglutide on CKD
Description
Kim GL, Song JG, Han HK
Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes
helping to make you feel fuller faster and for longer
The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy
Positive clinical evidence demonstrating improvements in liver inflammation and fibrosis is encouraging investment in late-stage clinical development and combination therapies
Available from: 38
